Tenvir AF tablet

Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor. It works by blocking the reverse transcriptase enzyme. The HIV virus needs this enzyme to replicate inside the body. Without it, the virus cannot convert its RNA into DNA. Replication stops.

The compound reaches target cells at high concentration. At the same time it keeps lower levels in the bloodstream compared to older tenofovir formulations. This matters for buyers stocking antiviral product lines. Lower systemic exposure means a cleaner side effect profile at the product level.

Product Information

Tenvir AF tablet contains Tenofovir Alafenamide as its active ingredient. It is manufactured by Cipla Ltd. Cipla is one of the most recognized generic pharmaceutical manufacturers globally. The tablet sits within the nucleotide reverse transcriptase inhibitor drug class. Tenvir AF carries strong market recognition among buyers sourcing HIV treatment products for resale and distribution.

What This Product Treats

Tenvir AF tablet is used in the treatment of HIV type 1 infection. It is part of combination antiretroviral therapy regimens. The product is used for chronic viral suppression in HIV positive individuals. Demand for this category remains consistently high across procurement markets.

Available Strengths and Pack Sizes

Buyers sourcing Tenvir AF tablet in bulk should confirm available strengths and pack configurations directly with the supplier. Pack sizes may vary by procurement channel. The product is typically stocked in standard strip and bottle formats suited to wholesale distribution. Resellers building HIV treatment product ranges regularly include this product alongside other nucleotide reverse transcriptase inhibitor lines.

Side Effect

The side effect profile of Tenvir AF tablet is consistent with nucleotide reverse transcriptase inhibitor compounds. Reported effects include nausea, headache, fatigue, and gastrointestinal discomfort.

Tenofovir Alafenamide delivers active drug at lower plasma concentrations than earlier tenofovir prodrugs. Because of this the renal and bone density impact profile is considered more favorable. This is a relevant characteristic for buyers comparing antiviral lines. Stockists often highlight this distinction when positioning the product in competitive procurement tenders.

Shelf Life and Storage

Tenvir AF tablet should be stored at controlled room temperature. Keep away from direct heat, moisture, and light. It comes in reusable, re-capable bottle

Wholesale buyers stocking large volumes should ensure warehouse conditions stay stable. Shelf life is consistent with standard oral solid dosage antiretroviral products. Always verify expiry dates at the batch level before committing to large volume orders.

Pricing and Availability

Get HIV Treatment stocks Tenvir AF tablet at pricing suited to reseller and wholesale procurement. Pricing is available per strip and per unit for bulk order enquiries. Contact the supplier directly for volume-based pricing. The product can be sourced through standard pharmaceutical supply channels.

Why Buyers Stock This Product

Cipla Ltd has a long-standing reputation for quality-consistent generic manufacturing. The Tenvir brand line is one of its most recognized antiretroviral product families. Demand for Tenofovir Alafenamide-based products has grown steadily. Prescribers and treatment programs have been shifting toward formulations with a more favorable systemic exposure profile.

Resellers sourcing HIV treatment products consistently include Tenvir AF tablet in their procurement lists. Reliable supply, established manufacturer credentials, and strong end-market demand are the main reasons. For wholesale buyers building a complete antiretroviral product range, this is a high-turnover line from a manufacturer with proven regulatory standing.

Tenvir AF tablet from Cipla Ltd has consistent demand across reseller and wholesale procurement channels. Buyers looking for a reliable supplier with transparent pricing can place enquiries through Get HIV Treatment.